Latest Conference Articles

Investigators recruited children with CVI and normal controls who were between the ages of 12 months and 12 years. They concluded that children with CVI have markedly lower VS-QOL compared to typically developing children.

Kelsey Roelofs, MD, gives her best methods to identifying and diagnosing thyroid eye disease in her Controversies in Modern Eye Care 2024 presentation.

Mary Beth Yackey, OD, and Michael Javaheri, MD, share their perspectives on the modernization of geographic atrophy identification and treatment.

Deborah Ristvedt, DO, details her CIME 2024 presentation on new glaucoma management options, led alongside Inder Paul Singh, MD, Arsham Sheybani, MD, and Melissa Tawa, OD, FAAO.

CIME Cochair Neda Shamie, MD, gives an overview of presentations on Demodex blepharitis, LASIK, retina sessions, and more at this year's conference.

Older age and longer duration of type 1 diabetes also play a role in the development of diabetic retinopathy, according to a chart review.

This study also found that upon discontinuation, myopia development did not rebound, with NVK002 0.01% as a potential long-term treatment for pediatric myopia.

David A. Berntsen, OD, PhD, FAAO, talks through his 2024 ARVO presentation on the BLINK2 study and the findings on axial growth after discontinuing soft multifocal contact lens wear.

The investigators induced experimental autoimmune encephalomyelitis in 15 female mice by immunizing them with myelin oligodendrocyte glycoprotein 33-55 in complete Freund’s adjuvant and pertussis toxin.

James A Katz, MD, details treatment options for Demodex blepharitis, from tea tree oil to XDEMVY.

The Patient Whisperers Cofounders Lauren Weaver and Christine Scarlett gave their keynote presentation "The Secret to Crazy Growth: Defining Your Identity on Social Media," at the 2024 Controversies in Modern Eye Care meeting May 4 in Los Angeles, California.

The collective enhances education, research, and quality of life.

Neda Shamie, MD, previews a collaborative day packed with guest speakers, discussions on advanced patient care, and hands-on labs.

Controversies in Modern Eye Care cochair Arjan Hura, MD, details new expansions to the conference's schedule, which include discussions on retina gene therapies, corneal endothelial diseases, and oculoplastics.

The World Council of Optometry partners with key optometric organizations for 2025 conference and appoints expert leaders in myopia management for education and outreach.

Before the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment.

Nicholas Gilberg, OD, with EssilorLuxxotica's Leonardo team walks through the basics of the education software that can be implemented in any practice.

Laura Periman, MD, talks through what was gained from the conference, from becoming acquainted with new technological advancements to renewing passion for dry eye care.

The newest technology, fashion trends, and business developments that were featured at this year’s show.

Scott Moscow, OD, talks his practice's contact lens "test-driving" option and how to get patients on board with trying out new corrective eyewear.

At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.

Alysse Henkel, vice president of research and inSights at The Vision Council, details recent research conducted by the company regarding consumer purchasing habits and trends.

Report findings show that patient interest in contact lenses can be dissuaded by lack of recommendations by eye care providers.

Mile Brujic, OD, FAAO, speaks on the power of Rinsada to bust biofilms at Vision Expo East 2024.

According to the company, its Virtual Eye Pro features improve visual field testing for practice and patients.

Dr Brianna Rhue, OD, FAAO, FSLS details her upcoming presentation "Cutting Out Surgery for the Management of Refractive Error," where she will detail the underutilization of orthokeratology during Vision Expo East 2024 later this week.

This year’s conference, held from March 14-17, will be its last in New York City.